Fool.com
The World's Greatest Investing Community
Results 1 - 10 of 492 : 1 2 3 4 5 6 7 8 9 Next
Eye on Insiders: Johnson & Johnson
Go inside the numbers on insider buying and selling.
Will These Investments Beat Immediate Annuities?
You might want to build your own alternative.
Gone but not forgotten, in semi-free verse.
It still has a big bet ahead of it, though.
Eli Lilly: Warming Up or Cooling Off?
Make sure you're holding the right stocks.
Shrugging Off the Side Effects
Sanofi is looking good, but still faces the loss of Lovenox.
It's Not As Frightening As It First Appears
Warning: generic adjustments ahead.
Of One-Time Gains and Pipelines
AstraZeneca had some of both during the third quarter.
World's Scariest Stocks: Pfizer
It may be a known unknown, but it still gives me the willies.
The Waters Aren't Flowing. Yet.
Thank goodness for cost cutting.
Legal Information © 1995 - 2009 The Motley Fool. All rights reserved.
Market Data provided by 
Terms & Conditions
RSS Headlines
Fool UK